SEPSIS Act
Summary
The SEPSIS Act (HR7116) was introduced in the House on 2026-01-15 and referred to the Energy and Commerce Committee. The bill authorizes CDC education campaigns and data collection on sepsis but does not specify any funding amount. The companion bill S1929 has been referred to the HELP Committee. At this early procedural stage with zero funding authorized, there is no direct revenue impact to any public company.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The SEPSIS Act authorizes CDC programs but no spending; it commands zero dollars.
- 2.No public company has any direct revenue exposure to this bill.
- 3.The companion bill S1929 is in the Senate HELP Committee, but without appropriations, the bill is a procedural placeholder.
Market Implications
No sector or company faces a direct revenue change from this bill as introduced. The CDC education campaign does not involve contracting with health systems or diagnostic makers. Until the bill is paired with an appropriation, it is not an investable event. Healthcare quality improvement proposals rarely move stock prices without a clear procurement or reimbursement mechanism.
Full Analysis
The SEPSIS Act (HR7116) was introduced on January 15, 2026, by Rep. Norcross (D-NJ-1) with original cosponsor Rep. Kean (R-NJ-7) and five additional bipartisan cosponsors. The bill has been referred to the House Committee on Energy and Commerce. The companion Senate bill S1929 has also been referred to the HELP Committee. The bill's findings note 1.7M annual sepsis cases and 350K deaths, citing Rory's Regulations in New York as a proven protocol. The bill text directs the CDC to maintain a sepsis team and lead education campaigns, and to improve pediatric sepsis data collection. The bill authorizes no specific dollar amount — it is an authorization to set up programs, not an appropriation. Funding would require a separate appropriations bill. There is no federal procurement mechanism or tax credit for private companies. The legislation is in the earliest procedural stage with zero funding authorized. No public company faces a direct revenue impact from this bill as currently drafted. The bipartisan cosponsorship and companion bill indicate moderate legislative momentum, but the lack of any funding mechanism means the bill has no near-term market impact on any sector beyond potential healthcare quality improvement.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →